WESPAC Advisors LLC Takes $712,000 Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

WESPAC Advisors LLC acquired a new stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 41,109 shares of the real estate investment trust’s stock, valued at approximately $712,000.

Other hedge funds have also made changes to their positions in the company. Geode Capital Management LLC boosted its position in shares of Sabra Health Care REIT by 1.7% in the 3rd quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock valued at $117,165,000 after purchasing an additional 104,533 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Sabra Health Care REIT by 222.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock valued at $183,996,000 after purchasing an additional 6,819,919 shares during the period. Vestcor Inc boosted its position in shares of Sabra Health Care REIT by 62.5% in the 3rd quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust’s stock valued at $3,869,000 after purchasing an additional 79,956 shares during the period. Barclays PLC boosted its position in shares of Sabra Health Care REIT by 56.1% in the 3rd quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust’s stock valued at $12,624,000 after purchasing an additional 243,895 shares during the period. Finally, Franklin Resources Inc. boosted its position in shares of Sabra Health Care REIT by 12.3% in the 3rd quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock valued at $9,543,000 after purchasing an additional 57,551 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Health Care REIT Price Performance

SBRA stock opened at $15.89 on Friday. The stock has a 50-day moving average price of $16.85 and a two-hundred day moving average price of $17.62. Sabra Health Care REIT, Inc. has a 12-month low of $13.31 and a 12-month high of $20.03. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The company has a market cap of $3.78 billion, a PE ratio of 29.98, a price-to-earnings-growth ratio of 1.97 and a beta of 1.25.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.36. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The firm had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. As a group, research analysts predict that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Friday, February 14th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 7.55%. The ex-dividend date of this dividend is Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is 226.42%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on SBRA. Mizuho reissued a “neutral” rating and issued a $20.00 target price on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research report on Tuesday, January 7th. Finally, Truist Financial cut Sabra Health Care REIT from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $18.00 to $17.00 in a research report on Friday, January 17th. Three research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.